
Akeso Biopharma
A clinical-stage biopharmaceutical company committed to in-house discovery, development and commercialization of first-in-class and best-in-class therapies.
Market cap
$16.5b
Enterprise value
$16.2b
Share price
HKD154.30 9926.HK
Authorizing premium user...